Welcome to today’s Five at Five – the EOB snapshot of the five most impactful market stories shaping investor sentiment.
GSK chief executive Emma Walmsley to step down at end of December – After nearly a decade at the helm, Walmsley will exit the pharmaceutical giant at year-end, setting the stage for a pivotal leadership transition. Read more …
Coal returns to Washington’s agenda after Trump initiative – A White House push to revive domestic coal production has put the sector back in focus, sparking political debate and investor interest. Read more …
FTSE 100 live: Miners and GSK lead gains as oil retreats from highs – London’s blue chips were lifted by resource stocks and pharma strength, though falling crude prices kept broader sentiment in check. Read more …
Electronic Arts to go private in $55 billion deal as rival bids fade – Analysts see little chance of a competing offer after the video game group agreed terms for a blockbuster leveraged buyout. Read more …
Coinsilium boosts balance sheet with Forza Bitcoin, eyes $YELLOW token launch – Executives outline digital asset strategy and near-term product rollouts in a Proactive Watch interview. Watch here …
More small cap news
EnergyPathways PLC (AIM:EPP) says its flagship MESH project has been granted nationally significant status by the UK government. The Irish Sea hub will combine storage, clean power, hydrogen and other low-carbon outputs to support the UK’s energy needs. Read more
Light Science Technologies Holdings PLC (AIM:LST) has won new Building Safety Act accreditation for its Passive Fire Protection division. It covers higher-risk buildings above 18 metres and is expected to speed up project approvals across the industry. Read more
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has agreed a new supply deal with the University of Virginia Health. The agreement provides more equipment as UVA upgrades to full clinical Xenon MRI use later this year. Read more
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has announced clinical data from a glioblastoma study using its Parsortix system. Circulating tumour cells were found in 60% of patients, opening new possibilities for monitoring and treatment research. Read more
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF) says it has funding in place until 2027 as trial activity builds. Phase 2a testing of lead drug POLB 001 is expected to deliver interim data in 2026. Read more
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF) reported first-half revenues of £1.29 million, reflecting lower oil prices and a weaker US dollar. It raised £2 million to fund new drilling in Oklahoma, with three wells already in progress. Read more